Sign Up to like & get
recommendations!
0
Published in 2022 at "AntiCancer Research"
DOI: 10.21873/anticanres.16121
Abstract: Background/Aim: Bevacizumab-containing chemotherapy constitutes an important salvage treatment for recurrent/refractory glioblastoma(r/rGBM). Patients and Methods: We retrospectively collected the data of r/rGBM patients treated with the combination of bevacizumab and irinotecan (BEV+IRI) as their salvage treatment…
read more here.
Keywords:
bevacizumab irinotecan;
glioblastoma rgbm;
bevacizumab;
bev iri ... See more keywords